Literature DB >> 15100105

Radiographic appearance and clinical outcome correlates in 26 patients with severe acute respiratory syndrome.

Shu-Chiang Hsieh1, Wing P Chan, Jerry Chin-Wei Chien, Wen-Sen Lee, Min-Szu Yao, Wai-Man Choi, Chia-Yuen Chen, Chun Yu.   

Abstract

OBJECTIVE: We aimed to evaluate the appearance of chest radiographs in patients with severe acute respiratory syndrome (SARS) and correlate these findings with clinical outcomes.
MATERIALS AND METHODS: We retrospectively reviewed the initial radiograph and a series of follow-up chest radiographs in 26 patients who had symptoms and signs consistent with SARS. Twenty-five patients completed the full course of radiographs in the hospital. The initial radiographic features and the distribution of parenchymal, mediastinal, and pleural abnormalities for each patient were evaluated. Follow-up radiographic findings were correlated with clinical outcomes for these patients.
RESULTS: Initial chest radiographs showed abnormalities in 23 (88%) of 26 subjects. Eighteen patients (69%) had air-space consolidation, two (8%) had ground-glass attenuation, one (4%) had nodules, and two (8%) had mixed consolidation and nodules. Four patients (15%) had pleural effusion. Younger patients and those with normal initial radiographic findings or unifocal lung lesions had better outcomes.
CONCLUSION: The initial predominant radiographic feature of SARS was air-space consolidation in the lateral and lower lung zones. Progressive deterioration to diffuse unilateral or bilateral consolidation in the series of follow-up chest radiographs is associated with a poor prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15100105     DOI: 10.2214/ajr.182.5.1821119

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

2.  Comparison of initial high resolution computed tomography features in viral pneumonia between metapneumovirus infection and severe acute respiratory syndrome.

Authors:  Cheuk Kei Kathy Wong; Vincent Lai; Yiu Chung Wong
Journal:  Eur J Radiol       Date:  2011-03-25       Impact factor: 3.528

Review 3.  Clinical management and infection control of SARS: lessons learned.

Authors:  Vincent C C Cheng; Jasper F W Chan; Kelvin K W To; K Y Yuen
Journal:  Antiviral Res       Date:  2013-08-28       Impact factor: 5.970

4.  Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2.

Authors:  Tomas Franquet; Yeon Joo Jeong; Hiu Yin Sonia Lam; Ho Yuen Frank Wong; Yeun-Chung Chang; Myung Jin Chung; Kyung Soo Lee
Journal:  Br J Radiol       Date:  2020-07-06       Impact factor: 3.039

5.  A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome.

Authors:  Yung-Liang Wan; Pei-Kwei Tsay; Yun-Chung Cheung; Ping-Cherng Chiang; Chun-Hua Wang; Ying-Huang Tsai; Han-Ping Kuo; Kuo-Chien Tsao; Tzou-Yien Lin
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

6.  Adverse Initial CT Findings Associated with Poor Prognosis of Coronavirus Disease.

Authors:  YoungJun Chon; Jin Young Kim; Young Joo Suh; Ji Yeon Lee; Jae Seok Park; Sung Min Moon; Mu Sook Lee; Jaehyuck Yi
Journal:  J Korean Med Sci       Date:  2020-08-31       Impact factor: 2.153

Review 7.  Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

Authors:  Jasper F W Chan; Kenneth S M Li; Kelvin K W To; Vincent C C Cheng; Honglin Chen; Kwok-Yung Yuen
Journal:  J Infect       Date:  2012-10-13       Impact factor: 6.072

8.  The characteristics and clinical value of chest CT images of novel coronavirus pneumonia.

Authors:  X Zhao; B Liu; Y Yu; X Wang; Y Du; J Gu; X Wu
Journal:  Clin Radiol       Date:  2020-03-19       Impact factor: 2.350

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.